A61K 35/765
Reovirus
Official title: Reovirus; Rotavirus
A61K35/765 (Reovirus) appears on 67 US grants and 105 published applications in this corpus.
Search patents in A61K- Granted patents
- 67
- Published applications
- 105
- Assignees
- 36
- Inventors
- 102
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 2 | 0 |
| 2001 | 1 | 2 |
| 2002 | 2 | 8 |
| 2003 | 3 | 4 |
| 2004 | 3 | 8 |
| 2005 | 0 | 8 |
| 2006 | 4 | 4 |
| 2007 | 8 | 4 |
| 2008 | 4 | 8 |
| 2009 | 2 | 8 |
| 2010 | 6 | 3 |
| 2011 | 3 | 5 |
| 2012 | 1 | 4 |
| 2013 | 2 | 2 |
| 2014 | 3 | 1 |
| 2015 | 2 | 2 |
| 2016 | 0 | 1 |
| 2017 | 2 | 3 |
| 2018 | 1 | 4 |
| 2019 | 3 | 6 |
| 2020 | 4 | 6 |
| 2021 | 2 | 3 |
| 2022 | 3 | 5 |
| 2023 | 1 | 3 |
| 2024 | 2 | 3 |
| 2025 | 2 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Delivery of oncolytic viruses using dendritic cells21 Apr 2026US 12,606,796 B2Sator Therapeutics
- Recombinant oncolytic viruses for treatment of metastatic cancers5 Aug 2025US 12,378,289 B2Entos Pharmaceuticals Inc.
- Oncolytic reovirus13 May 2025US 12,295,977 B2
- Materials and methods for treatment with oncolytic viruses and modified CAR T cells22 Oct 2024US 12,121,554 B2Duke University
- Altered virus13 Aug 2024US 12,059,444 B2Replimune Limited
- Altered virus31 Oct 2024US 2024/0358781 A1Replimune Limited
- Novel modified reovirus and use thereof8 Feb 2024US 2024/0041959 A1Virocure, Inc.
- Pharmaceutical composition for preventing or treating cancer, comprising squirrel fibroma virus and reovirus25 Jan 2024US 2024/0024393 A1Virocure, Inc.
- Pharmaceutical composition of enzymes and viruses and application thereof7 Sep 2023US 2023/0277633 A1Shanghai Bao Pharmaceuticals Co., Ltd.
- Pharmaceutical composition for preventing or treating cancer3 Aug 2023US 2023/0241141 A1Virocure, Inc.
Most cited
By later US patents
- Reovirus for the treatment of cellular proliferative disorders56US 6,136,307 AOncolytics Biotech Inc. · 2000
- Reovirus for the treatment of neoplasia46US 6,110,461 AOncolytics Biotech Inc. · 2000
- Reovirus for the treatment of neoplasia22US 6,261,555 B1Oncolytics Biotech Inc. · 2001
- Method of producing infectious reovirus22US 6,528,305 B2Oncolytics Biotech Inc. · 2003
- Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders22US 6,565,831 B1Oncolytics Biotech Inc. · 2003